Updated Jul 16, 2026
Tomkiel Melissa M. has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.18M.

Melissa M. Tomkiel serves as the President and General Counsel of Strata Critical Medical, Inc., where she has held various roles including Co-CEO and Director. She has been involved in the company's operations and strategic direction within the healthcare logistics sector.
| Role | Co-CEO and General Counsel, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture | 29.7K | $5.87 | $175K |
| 2026-06-10 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale | 29.7K | $5.87 | $175K |
| 2026-04-27 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture | 321.8K | $4.92 | $1.58M |
| 2026-04-27 | SRTA | Strata Critical Medical, Inc. | A — Grant or award | 630.3K | $0.00 | |
| 2026-03-10 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture | 29.4K | $4.54 | $133K |
| 2025-10-10 | SRTA | Strata Critical Medical, Inc. | M — Option exercise | 55.6K | $0.18 | $10K |
| 2025-09-10 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture | 34.0K | $4.00 | $136K |
| 2025-08-06 | SRTA | Strata Critical Medical, Inc. | M — Option exercise | 23.9K | $0.18 | $4K |
| 2025-08-06 | SRTA | Strata Critical Medical, Inc. | M — Option exercise | 20.5K | $0.18 | $4K |
| 2025-08-01 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale | 48.0K | $4.94 | $237K |
| 2025-08-01 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture | 81.1K | $3.99 | $323K |
| 2025-08-01 | SRTA | Strata Critical Medical, Inc. | A — Grant or award | 160.7K | $0.00 | |
| 2024-12-11 | SRTA | Strata Critical Medical, Inc. | F — Tax withholding / forfeiture [10b5-1] | 34.0K | $4.72 | $161K |
| 2024-12-11 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale [10b5-1] | 22.5K | $5.01 | $113K |
| 2024-11-29 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale [10b5-1] | 22.1K | $5.02 | $111K |
| 2024-11-29 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale [10b5-1] | 44.6K | $4.50 | $201K |
| 2024-11-29 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale [10b5-1] | 44.6K | $4.25 | $190K |
| 2024-11-13 | SRTA | Strata Critical Medical, Inc. | S — Open-market sale [10b5-1] | 44.6K | $3.40 | $152K |
Melissa M. Tomkiel serves as the President and General Counsel of Strata Critical Medical, Inc., where she has held various roles including Co-CEO and Director. She has been involved in the company's operations and strategic direction within the healthcare logistics sector.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($1.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tomkiel Melissa M. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.